Oncogenesis

Papers
(The H4-Index of Oncogenesis is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
MYB oncoproteins: emerging players and potential therapeutic targets in human cancer101
Exosomes and cancer - Diagnostic and prognostic biomarkers and therapeutic vehicle99
Single-cell RNA sequencing reveals cell heterogeneity and transcriptome profile of breast cancer lymph node metastasis83
Lipids in cancer: a global view of the contribution of lipid pathways to metastatic formation and treatment resistance70
Understanding the common mechanisms of heart and skeletal muscle wasting in cancer cachexia70
TGF-β1-mediated transition of resident fibroblasts to cancer-associated fibroblasts promotes cancer metastasis in gastrointestinal stromal tumor60
Metformin exhibits antiproliferation activity in breast cancer via miR-483-3p/METTL3/m6A/p21 pathway53
miR-18a promotes glioblastoma development by down-regulating ALOXE3-mediated ferroptotic and anti-migration activities52
RETRACTED ARTICLE: PI3K/Akt pathway and Nanog maintain cancer stem cells in sarcomas47
IL-6 promotes drug resistance through formation of polyploid giant cancer cells and stromal fibroblast reprogramming43
LONP1 and ClpP cooperatively regulate mitochondrial proteostasis for cancer cell survival39
Diethyldithiocarbamate-copper complex (CuET) inhibits colorectal cancer progression via miR-16-5p and 15b-5p/ALDH1A3/PKM2 axis-mediated aerobic glycolysis pathway38
Triptolide targets super-enhancer networks in pancreatic cancer cells and cancer-associated fibroblasts38
USP29-mediated HIF1α stabilization is associated with Sorafenib resistance of hepatocellular carcinoma cells by upregulating glycolysis37
YAP/TAZ inhibition reduces metastatic potential of Ewing sarcoma cells34
Dissecting the single-cell transcriptome network in patients with esophageal squamous cell carcinoma receiving operative paclitaxel plus platinum chemotherapy32
Feedback activation of STAT3 limits the response to PI3K/AKT/mTOR inhibitors in PTEN-deficient cancer cells32
Breast cancer in the era of integrating “Omics” approaches30
Neutrophils and polymorphonuclear myeloid-derived suppressor cells: an emerging battleground in cancer therapy29
Epigenetic regulation of TGF-β-induced EMT by JMJD3/KDM6B histone H3K27 demethylase29
Angiogenesis and immune checkpoint dual blockade in combination with radiotherapy for treatment of solid cancers: opportunities and challenges28
OXER1 and RACK1-associated pathway: a promising drug target for breast cancer progression27
Emerging role of SWI/SNF complex deficiency as a target of immune checkpoint blockade in human cancers27
Involvement of the pro-oncogenic enzyme fatty acid synthase in the hallmarks of cancer: a promising target in anti-cancer therapies27
Tumour heterogeneity and evolutionary dynamics in colorectal cancer26
Tumor-secreted exosomal Wnt2B activates fibroblasts to promote cervical cancer progression26
0.039091110229492